1Daniela S. Krause,Richard A. et al. Tyrosine kinases as targets for cancer therapy[J]. N Engl J MDE,2005,353(2):172-187.
2Sebastian S, Settleman J, Reshkin S J, et al. The complexity of targeting EGFR signalling in cancer: from expression to turnover[ J]. Biochim Biophys Acta,2006,1766( 1 ) :120-139.
3Smith KM, Yacobi R, Van Etten RA. Autoinhibition of Bcr-Abl through its SH3 domain[ J]. Mol Cell,2003,12:27-37.
4Lynch T, Bell DW, Sordella R, et al, Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib[J]. N Engl J Med, 2004,350: 2129-2139.
5Vanmeter AJ,Rodriguez AS,Bowman ED,et al. LCM and protein microarray analysis of human NSCLC : Differential EGFR phosphorylation events associated with mutated EGFR compared to wild type[ J ]. Mol Cell Proteomics,2008,7 (10) : 1902-1924.
6Wu Y, Mohamed H, Chillar R, et al. Clinical significance of Akt and HER2/neu overexpression in African-American and Latina women with breast cancer[ J ]. Breast Cancer Res, 2008,10 ( 1 ) : R3.
8Sobrero AF,Manrel J,Fehrenbacher L,et al. EPIC: phase Ⅲ trial of cetuximab plus irinotecan after fluorepyrlmidine and oxaliplatin failure in patients with metastatic colorectal cancer[J]. J Clin Oncol,2008,26(14) :2311-2319.
9Van Cutsem E, Nowaeki M, Lang I, et al. Randomized phase Ⅲ study of irinotecan and 5-FU/FA with or without cetuximab in the first-line treatment of patients with metastatic colorectal cancer (mCRC) : the CRYSTAL trial[ J]. J Clin Oncol,2007,25 (18s): 4000.
10R. Pirker,A. Szezesna,J. von Pawel,et al. A randomized,multi center,phase Ⅲ study of cetuximab in combination with cisplatin/ vinorelbine (CV) versus CV alone in the first-line treatment of patients with advanced non-small cell lung cancer(NSCLC) [ J]. J Clin Oncol,2008,26 : ( May 20 suppl; abstr 3 ).
8PORT Meta-analysis Trialists Group. Postoperative radiotherapy in non-small cell lung cancer: Systematic review and meta-analysis of individual patient data from nine randomised controlled trials. PORT Meta-analysis Trialists Group[J]. Lancet, 1998, 25, 352(9124): 257-263.
10Lally BE, Zelterman D, Colasanto JM, et al. Postoperative radiotherapy for stage Ⅱ or Ⅲ non-small cell lung cancer using the surveillance, epidemiology, and end results database [ J ] . J Clin Oncol, 2006, 24(19): 2998-3006.
